Ginsenoside Rg1 protects neurons from hypoxic-ischemic injury possibly by inhibiting Ca2+ influx through NMDA receptors and L-type voltage-dependent Ca2+ channels

European Journal of Pharmacology

Volumn 586, Issue 1-3, 2008, Pages 90-99

  Zhang, Yun Feng ^a   Fan, Xing Juan ^a   Li, Xia ^a   Peng, Liang Liang ^a   Wang, Guo Hua ^a   Ke, Kai Fu ^a   Jiang, Zheng Lin ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Calcium overload; Focal cerebral ischemia reperfusion; Ginsenoside Rg1; L type voltage dependent calcium channels; Neuroprotection; NMDA receptors

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM CHANNEL L TYPE; CASPASE 3; GINSENOSIDE RG 1; LACTATE DEHYDROGENASE; MIFEPRISTONE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POTASSIUM CHLORIDE; CALCIUM; GINSENOSIDE; GLUCOSE; HORMONE ANTAGONIST; NEUROPROTECTIVE AGENT; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CALCIUM TRANSPORT; CELL CULTURE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; ELECTRIC ACTIVITY; ENZYME ACTIVATION; ENZYME RELEASE; HIPPOCAMPUS; HYPOXIA; IMMUNOHISTOCHEMISTRY; ISCHEMIA; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL LESION; NEUROPROTECTION; NISSL STAINING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BRAIN ISCHEMIA; CELL SURVIVAL; CEREBRAL ARTERY DISEASE; CYTOLOGY; DRUG EFFECT; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GINSENOSIDES; GLUCOSE; HIPPOCAMPUS; HORMONE ANTAGONISTS; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; MALE; MIFEPRISTONE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TETRAZOLIUM SALTS; THIAZOLES;

EID: 43549126841     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.12.037     Document Type: Article

References (48)

1. Abraham I.M., Harkany T., Horvath K.M., and Luiten P.G. Action of glucocorticoids on survival of nerve cells: promoting neurodegeneration or neuroprotection?. J. Neuroendocrinol. 13 (2001) 749-760
2. Amaral D.G., and Witter M.P. The three dimensional organization of the hippocampal formation: a review of anatomical data. Neuroscience 31 (1989) 571-591
3. Anderson D.C., and Cranford R.E. Corticosteroids in ischemic stroke. Stroke 10 (1979) 68-71
4. Ashe P.C., and Berry M.D. Apoptotic signaling cascades. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 (2003) 199-214
5. Attele A.S., Wu J.A., and Yuan C.S. Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol. 58 (1999) 1685-1693
6. 2+ signals and death programmes in neurons. Philos. Trans. R. Soc. Lond., B 360 (2005) 2255-2258
7. 1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur. J. Pharmacol. 473 (2003) 1-7
8. Cheng Y.D., Al-Khoury L., and Zivin J.A. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx 1 (2004) 36-45
9. 1 down-regulates glucocorticoid receptor and displays synergistic effects with cAMP. Steroids 63 (1998) 421-424
10. Curry S.H. Why have so many drugs with stellar results in laboratory stroke models failed in clinical trials? A theory based on allometric relationships. Ann. N.Y. Acad. Sci. 993 (2003) 69-74
11. Fairchild M.D., Parsons J.E., Wasterlain C.G., Rinaldi P.C., and Wallis R.A. A hypoxic injury potential in the hippocampal slice. Brain Res. 453 (1988) 357-361
12. Gerriets T., Li F., Silva M.D., Meng X., Brevard M., Sotak C.H., and Fisher M. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J. Neurosci. Methods 122 (2003) 201-211
13. Gladstone D.J., Black S.E., and Hakim A.M. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33 (2002) 2123-2136
14. Graham S.H., and Chen J. Programmed cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 21 (2001) 99-109
15. Heiland S., Reith W., Forsting M., and Sartor K. Perfusion-weighted magnetic resonance imaging using a new gadolinium complex as contrast agent in a rat model of focal cerebral ischemia. J. Magn. Reson. Imaging 7 (1997) 1109-1115
16. Ji Y.C., Kim Y.B., Park S.W., Hwang S.N., Min B.K., Hong H.J., Kwon J.T., and Suk J.S. Neuroprotective effect of ginseng total saponins in experimental traumatic brain injury. J. Korean Med. Sci. 20 (2005) 291-296
17. 1 on ischemic brain injury in rat. J. Apoplexy Nerv. Dis. 20 5 (2003) 415-417
18. Jiang Z.L., Chen Y.R., Zhou C., Shi J.S., and Duan S.M. Glutamate-related mechanisms of ginsenosides against hypoxic-ischemic brain damage. Chin. J. Appl. Physiol. 17 (2001) 105-108
19. Jiang Z.L., Wu X.M., Jin S.Y., Chen Y.P., and Zhuang J. Effect of ginsenosides on hypoxic brain injury in hippocampal slice. Chin. J. Naut. Med. 7 (2000) 28-32
20. Jonas S., Aiyagari V., Vieira D., and Figueroa M. The failure of neuronal protective agents versus the success of thrombolysis in the treatment of ischemic stroke: the predictive value of animal models. Ann. N.Y. Acad. Sci. 939 (2001) 257-267
21. Kiefer D., and Pantuso T. Panax ginseng. Am. Fam. Phys. 68 (2003) 1539-1542
22. Kim S., and Rhim H. Ginsenosides inhibit NMDA receptor-mediated epileptic discharges in cultured hippocampal neurons. Arch. Pharm. Res. 27 (2004) 524-530
23. 3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. J. Neurosci. Res. 4 (1998) 426-432
24. Kim S., Ahn K., Oh T.H., Nah S.Y., and Rhim H. Inhibitory effect of ginsenosides on NMDA receptor-mediated signals in rat hippocampal neurons. Biochem. Biophys. Res. Commun. 296 (2002) 247-254
25. 3 antagonizes NMDA receptors through a glycine modulatory site in rat cultured hippocampal neurons. Biochem. Biophys. Res. Commun. 323 (2004) 416-424
26. 3 against homocysteine-induced excitotoxicity in rat hippocampus. Brain Res. 1136 (2007) 190-199
27. 1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol. Cell. Endocrinol. 133 (1997) 135-140
28. Lee J.H., Kim S.R., Bae C.S., Kim D.H., Hong H.N., and Nah S.Y. Protective effect of ginsenosides, active ingredients of Panax ginseng, on kainic acid-induced neurotoxicity in rat hippocampus. Neurosci. Lett. 325 (2002) 129-133
29. 2, a newly identified active ingredient of ginseng, inhibits NMDA receptors in cultured rat hippocampal neurons. Eur. J. Pharmacol. 536 (2006) 69-77
30. 2+ channel subtypes. Mol. Cells 21 (2006) 52-62
31. 1 in primary nigral neurons against rotenone toxicity. Neuropharmacology 52 (2007) 827-835
32. 1 in cultured cortical neurons. Chin. Med. J. 110 7 (1997) 535-539
33. 1 in cultured cortical neurons. Acta Pharm. Sin. 32 6 (1997) 406-410
34. 1 on spinal cord neurons in vitro. Exp. Neurol. 173 (2002) 224-234
35. 1, a main ingredient of ginseng root. Neurosci. Res. 28 (1997) 191-200
36. 1 on cultured hippocampal neurons. Acta Pharm. Sin. 30 9 (1995) 674-678
37. Love S. Apoptosis and brain ischaemia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 (2003) 267-282
38. 2+ channels through a pertussis toxin-sensitive G protein. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 8739-8743
39. 2+ channel currents in rat sensory neurons. Eur. J. Pharmacol. 436 (2002) 151-158
40. 1. Planta Med. 67 (2001) 533-537
41. 2+ elevation in mouse hippocampal slices. Biochem. Biophys. Res. Commun. 321 (2004) 510-513
42. Saver J.L., Kidwell C., Eckstein M., and Starkman S. Prehospital neuroprotective therapy for acute stroke: results of the field administration of stroke therapy-magnesium (FAST-MAG) pilot trial. Stroke 35 (2004) e106-e108
43. 2+ elevation in cultured rat hippocampal neurons. J. Neurochem. 83 (2002) 1441-1451
44. 3 on cerebral ischemia in rats. Neurosci. Lett. 374 (2005) 92-97
45. Van Kampen J., Robertson H., Hagg T., and Drobitch R. Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease. Exp. Neurol. 184 (2003) 21-29
46. Wen T.C., Yoshimura H., Matsuda S., Lim J.H., and Sakanaka M. Ginseng root prevents learning disability and neuronal loss in gerbils with 5-minute forebrain ischaemia. Acta Neuropathol. 91 (1996) 15-22
47. White B.C., Sullivan J.M., DeGracia D.J., O'Neil B.J., Neumar R.W., Grossman L.I., Rafols J.A., and Krause G.S. Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J. Neurol. Sci. 179 (2000) 1-33
48. 1 on reversible focal brain ischemia in rats. Acta Pharmacol. Sin. 17 1 (1996) 44-48